3 days Ago By ABMN Staff
StockNews.com upgraded shares of Joint ( NASDAQ:JYNT – Free Report ) from a hold rating to a buy rating in a report published on Friday. Separately, Roth Mkm cut their price target on shares of Joint from $16.
00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. View Our Latest Report on Joint Joint Price Performance Hedge Funds Weigh In On Joint Several hedge funds and other institutional investors have recently modified their holdings of the company.
Ancora Advisors LLC raised its holdings in Joint by 105.0% in the first quarter. Ancora Advisors LLC now owns 99,212 shares of the company’s stock valued at $1,296,000 after buying an additional 50,815 shares during the period.
Clayton Partners LLC lifted its holdings in shares of Joint by 38.1% during the 2nd quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock valued at $2,622,000 after acquiring an additional 51,500 shares in the last quarter.
Los Angeles Capital Management LLC purchased a new stake in Joint during the 2nd quarter worth $1,115,000. American Century Companies Inc. increased its holdings in Joint by 47.
7% in the 2nd quarter. American Century Companies Inc. now owns 24,170 shares of the company’s stock valued at $340,000 after purchasing an additional 7,804 shares in the last quarter.
Finally, Dimensional Fund Advisors LP raised its position in Joint by 9.8% in the second quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company’s stock valued at $2,730,000 after purchasing an additional 17,268 shares during the period.
76.88% of the stock is owned by institutional investors and hedge funds. About Joint ( Get Free Report ) The Joint Corp.
operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp.
was incorporated in 2010 and is headquartered in Scottsdale, Arizona. Featured Stories Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter .
.
